| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_aea57db10fe6e572d4a54808447081e9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ee0b54f4d2991760c71d9fd631ac707f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_216158693e667d561bd2a63ea37ab3f2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cdce39138b19320b1afb05d30d4e6cda
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3e5df17c4df22f8152f9847a9d7c09da
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cfc5a211265f86142ba0d11729e12757 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-104
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2400-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-158 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6883
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-564 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N27-62
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-566
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N21-64 |
| filingDate |
2012-06-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_76e8dd26522963296f8bdd3814547489
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_090bbcab135ad654a4a35efebbd0c1cb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1a050dbfbce8eb8094c96bc79cb7bc5f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_44b0b95aca5294f4db3df611b18557e3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f5bfda354d0b76ecac251612796cc5ce |
| publicationDate |
2012-12-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2012308578-A1 |
| titleOfInvention |
SLE-DC-MEDIATED ENHANCED IgG- AND IgA-SECRETING B CELL RESPONSES |
| abstract |
The present invention provides a method for treating a patient at risk for or diagnosed systemic lupus erythematosus (SLE) by determining the overall expression of syndecan-1 in one or more cells of a patient suspected of having SLE; and predicting the efficacy of a therapy with a pharmaceutical agent for treating the patient, wherein a decrease in the overall expression of syndecan-1 in the patient cells when compared to the expression of syndecan-1 in normal cells indicates a predisposition to responsiveness to anti-neoplastic agent therapy, wherein the therapy comprises administering an effective amount of the pharmaceutical agent to the patient. |
| priorityDate |
2011-06-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |